The global post-operative nausea and vomiting (PONV) market was valued at US$ 2.1 Bn in 2022 and is expected to expand at a CAGR of 7.4% from 2023 to 2031, reaching US$ 4.0 Bn by the end of 2031. The market is experiencing significant growth as healthcare providers increasingly focus on improving patient outcomes and enhancing post-surgical recovery experiences. PONV remains one of the most...